Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Inhibition of interleukin-5 mediated eosinophil viability by fluticasone 17-propionate: Comparison with other glucocorticoids
J. B. Hagan,
H. Kita
, G. J. Gleich
Allergic Diseases
Allergy, Asthma and Clinical Immunology
Research output
:
Contribution to journal
›
Article
›
peer-review
24
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Inhibition of interleukin-5 mediated eosinophil viability by fluticasone 17-propionate: Comparison with other glucocorticoids'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Fluticasone
100%
Interleukin-5
81%
Eosinophils
70%
Glucocorticoids
66%
beclomethasone 17-monopropionate
13%
Dexamethasone
12%
Interferons
12%
flunisolide
11%
Asthma
10%
Beclomethasone
9%
Triamcinolone Acetonide
8%
Budesonide
8%
Cytokines
8%
Propidium
7%
Granulocyte-Macrophage Colony-Stimulating Factor
6%
Inhibitory Concentration 50
5%
Hydrocortisone
5%
In Vitro Techniques
5%
Tissue Donors
5%
Flow Cytometry
5%
Staining and Labeling
4%
Pharmaceutical Preparations
2%